Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Reexamination Certificate
2007-06-21
2010-02-16
Zucker, Paul A (Department: 1621)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
C424S468000, C514S649000
Reexamination Certificate
active
07662407
ABSTRACT:
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
REFERENCES:
patent: 3819706 (1974-06-01), Mehta
patent: 6033686 (2000-03-01), Seth
patent: 6096341 (2000-08-01), Seth
patent: 6120803 (2000-09-01), Wong et al.
patent: 6210716 (2001-04-01), Chen et al.
patent: 6242496 (2001-06-01), Kulkarni et al.
patent: 6306436 (2001-10-01), Chungi et al.
patent: 6323236 (2001-11-01), McElroy
patent: 6337328 (2002-01-01), Fang et al.
patent: 6582737 (2003-06-01), Hirsh et al.
patent: 6589553 (2003-07-01), Li et al.
patent: 6905708 (2005-06-01), Li et al.
patent: 7241805 (2007-07-01), Oberegger et al.
patent: 7303756 (2007-12-01), Bodmeier
patent: 2007/0203231 (2007-08-01), Jonas et al.
patent: 2007/0212428 (2007-09-01), Wittlin
patent: 2007/0269516 (2007-11-01), Oberegger et al.
patent: 2007/0276047 (2007-11-01), Oberegger et al.
patent: 2007/0281012 (2007-12-01), Oberegger et al.
patent: 2009/019294 (2009-02-01), None
patent: 2009/056550 (2009-05-01), None
Berg et al. Pharmaceutical Salts J.Phar.Sci. 66(1) Jan. 1977, 19pp.
Nair LexOrbis Mar. 13, 2008, 2 pages.
Soroko et al. Jour.Clin.Psych. May 1983(44) 67-73.
U.S. Appl. No. 11/930,644, filed Oct. 31, 2007, Oberegger et al.
U.S. Appl. No. 11/834,848, filed Aug. 7, 2007, Oberegger et al.
U.S. Appl. No. 11/774,109, filed Jul. 6, 2007, Oberegger et al.
U.S. Appl. No. 11/766,239, filed Jun. 21, 2007, Oberegger et al.
U.S. Appl. No. 11/766,213, filed Jun. 21, 2007, Oberegger et al.
U.S. Appl. No. 11/762,820, filed Jun. 14, 2007, Oberegger et al.
U.S. Appl. No. 11/762,343, filed Jun. 13, 2007, Oberegger et al.
U.S. Appl. No. 11/762,840, filed Jun. 14, 2007, Oberegger et al.
U.S. Appl. No. 11/759,413, filed Jun. 7, 2007, Oberegger et al.
U.S. Appl. No. 60/693,906, filed Jun. 27, 2005, Oberegger et al.
U.S. Appl. No. 11/993,723, filed Dec. 21, 2007, Oberegger et al.
U.S. Appl. No. 11/768,764, filed Jun. 26, 2007, Nighiem et al.
U.S. Appl. No. 11/751,768, filed May 22, 2007, Oberegger et al.
U.S. Appl. No. 11/751,785, filed May 22, 2007, Oberegger et al.
U.S. Appl. No. 11/755,946, filed May 31, 2007, Oberegger et al.
U.S. Appl. No. 11/762,368, filed Jun. 13, 2007, Oberegger et al.
U.S. Appl. No. 11/768,764, filed Jun. 26, 2007, Jackson et al.
U.S. Appl. No. 12/536,772, filed Aug. 6, 2009, Turchetta et al.
Jackson Graham
Maes Paul
Oberegger Werner
Saleh Mohammad Ashty
Biovail Laboratories International S.R.L.
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Zucker Paul A
LandOfFree
Modified release formulations of a bupropion salt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified release formulations of a bupropion salt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified release formulations of a bupropion salt will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4170576